title: [Flash visual evoked potentials (FVEP) examination under midazolam sedation of non-cooperating children].
abstract: OBJECTIVE
  To find the optimal conditions for visual evoked potential (VEP) examination of non-cooperative children using midazolam maleate sedation.
  
  
  METHODS
  32 children aged from 8 months to 13 years (mean 3.5 years) with mental disorders, emotional problems and/or very low vision due to various reasons.
  
  
  METHODS
  VEP--flash and bright flash according to ISCEV standards. Midazolam maleate sedation 0.4-0.5 mg per kilo body weight, given orally.
  
  
  RESULTS
  Only 6 children aged from 11 months to 3.5 years (mean 2.5 years) required sedation for VEP examination. Midazolam sedation unabled VEP examination, was safe for children and well-tolerated.
  
  
  CONCLUSIONS
  Second degree sedation in Ramsey score is effective for good VEP examination of non-cooperative children.
authors.affiliation: Katedra i Oddział Kliniczny Okulistyki Slaskiej Akademii Medycznej w Katowicach, Szpital Specjalistyczny nr 1 w Bytomiu.
authors.forename: Dorota
authors.initials: D
authors.lastname: Pojda-Wilczek
authors.forename: Ludwik G
authors.initials: LG
authors.lastname: Stołtny
authors.forename: Stefan M
authors.initials: SM
authors.lastname: Pojda
authors.forename: Grzegorz
authors.initials: G
authors.lastname: Pojda
mesh_terms: D001007:Anxiety / Q000188:drug therapy*; D051017:Apoptosis Regulatory Proteins; D002135:Calcium-Binding Proteins; D002648:Child; D002675:Child, Preschool; D005074:Evoked Potentials, Visual / Q000502:physiology*; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*; D007223:Infant; D008297:Male; D001523:Mental Disorders / Q000150:complications / Q000523:psychology; D008874:Midazolam / Q000627:therapeutic use*; D019964:Mood Disorders / Q000150:complications / Q000523:psychology; D014786:Vision Disorders / Q000150:complications / Q000175:diagnosis*
chemical_list: D051017:Apoptosis Regulatory Proteins; C485604:CASP8AP2 protein, human; D002135:Calcium-Binding Proteins; D006993:Hypnotics and Sedatives; D008874:Midazolam